Two Florida nursing homes and a hospital allowed a hospice company to provide free services in exchange for patient referrals, according to recently unsealed whistleblower charges.
A whistleblower can continue to pursue charges that a Nevada healthcare network routinely admitted people as hospital inpatients when they should have been placed in observation status, a federal appeals court recently ruled.
Long-term care pharmacy Omnicare will not face False Claims Act penalties for drug packaging practices that apparently ran afoul of safety regulations. The U.S. Supreme Court has declined to take up the case, meaning that an appeals court ruling in Omnicare's favor will stand.
Skilled nursing facilities soon might be facing an onslaught of whistleblower lawsuits alleging "worthless services," a legal expert cautioned Tuesday.
A whistleblower can continue to pursue charges that a number of New Jersey physicians improperly designated Medicare beneficiaries as inpatients and sometimes prolonged their hospital stay to qualify them for skilled nursing care, a federal judge recently ruled.
The way mobile x-ray company Mobilex bills nursing homes is acceptable, a federal judge recently determined. Mobilex is the nation's largest provider of mobile diagnostic services. It had been facing whistleblower charges that it effectively paid kickbacks to nursing homes through an arrangement known as "swapping."
An Illinois nursing home won a victory last week when the U.S. Court of Appeals for the Seventh Circuit voided a $9 million verdict.
Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.
A hospitalist company that works with thousands of facilities is facing federal charges that its clinicians routinely overbilled Medicare and Medicaid, authorities recently announced.
A whistleblower can pursue charges that long-term care pharmacy Omnicare ignored skilled nursing companies' overdue bills in exchange for certain kinds of business, a federal district court recently ruled.
A whistleblower can keep pursuing his allegations that long-term care pharmacy Omnicare funneled payments to nursing home owners through so-called charitable donations, U.S. District Court Judge Robert M. Dow Jr. recently ruled. Dow dismissed other charges leveled in the suit.
Two nursing home therapy providers and a nursing home management company have agreed to pay $30 million to settle claims that they engaged in a kickback scheme, the U.S. Department of Justice has announced.
Michael Barr, who co-founded the company now known as Kindred Healthcare, has agreed to pay $1 million in a settlement over Medicare fraud charges, the U.S. Department of Justice announced Monday.
What do neck abnormalities, dangerous bacteria, a murder-suicide, a defensive nursing home chain, and antipsychotic guidelines have in common? These five developments were voted the most popular news stories appearing on the McKnight's website during 2013.
A Florida-based hospice provider has agreed to pay $3 million to settle a whistleblower lawsuit alleging false Medicare claims, the U.S. Department of Justice announced Wednesday.
The nation's second-largest ambulance services company has reached a settlement agreement over whistleblower charges of improper business dealings with skilled nursing facilities, Rural/Metro Corporation announced Tuesday.
Omnicare, the nation's largest provider of long-term care pharmacy services, has agreed to pay $120 million to settle a False Claims Act lawsuit over Medicare Part A drug pricing, the company announced Wednesday. The settlement likely is one of the largest in a whistleblower case in which the government did not intervene, according to Frederick Morgan, one of Gale's attorneys at the firm Morgan Verkamp LLC.
Long-term care pharmacy giant PharMerica dispensed controlled narcotics without valid prescriptions and charged Medicare, the federal government alleges in a False Claims Act lawsuit. The company "vigorously" disputes the claims.
One of the nation's largest providers of laboratory and X-ray services to skilled nursing facilities has agreed to pay $17.5 million to settle a whistleblower lawsuit alleging Medicare fraud.
The government has presented "thin" evidence against a nursing home therapy provider in a high-profile whistleblower case, but a jury still might reasonably find the therapy company guilty of paying kickbacks, a federal judge recently ruled.
PharMerica has been charged in a False Claims Act lawsuit by the federal government.
A whistleblower who alleges Omnicare Inc. paid kickbacks to nursing homes did not violate the False Claims Act, a judge has ruled.
Two nursing home operators are set to stand trial to face whistleblower allegations that Omnicare Inc. paid them kickbacks during its purchase of Total Pharmacy.
An Illinois federal judge approved the dismissal of a whistleblower lawsuit against Omnicare, following a settlement agreement on July 9, according to local media reports.
Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.
Comments made during a therapy provider's public conference call in 2006 aroused the suspicion of a listener, who went on to file a whistleblower lawsuit. This was disclosed in a recent court filing in the case, which pits the whistleblower and the U.S. government against RehabCare, the provider that hosted the 2006 call.
The Department of Labor has dismissed a whistleblower lawsuit filed by Laurie Bebo against the company she used to lead, Assisted Living Concepts, according to ALC's recently filed quarterly results.
A whistleblower lawsuit involving a nursing home chain and therapy providers in Missouri can move forward, a federal judge has ruled. The False Claims Act case originated with allegations that a therapy company received more than $10 million in kickbacks as part of a scheme to overbill Medicare and Medicaid.
The Department of Health and Human Services is trying to encourage Medicare fraud whistleblowers by substantially increasing their potential reward. The current maximum award of $1,000 would go up to $9.9 million per whistleblower if a recently proposed rule takes effect.
Biotechnology company Amgen will pay $24.9 million in a settlement over whistleblower allegations that the company paid kickbacks to long-term care pharmacies to increase the use of an anemia drug in nursing homes.